Legend Biotech Corp (LEGN)
40.00
+0.65
(+1.65%)
USD |
NASDAQ |
Nov 14, 12:47
Legend Biotech Shareholders Equity (Quarterly): 1.159B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.159B |
| March 31, 2024 | 1.164B |
| December 31, 2023 | 1.251B |
| September 30, 2023 | 1.340B |
| June 30, 2023 | 1.407B |
| March 31, 2023 | 653.16M |
| December 31, 2022 | 744.31M |
| June 30, 2022 | 562.63M |
| March 31, 2022 | 438.56M |
| Date | Value |
|---|---|
| December 31, 2021 | 765.94M |
| September 30, 2021 | 225.87M |
| March 31, 2021 | 206.45M |
| December 31, 2020 | 597.77M |
| September 30, 2020 | 334.90M |
| June 30, 2020 | 401.00M |
| March 31, 2020 | -15.88M |
| December 31, 2019 | -122.87M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-122.87M
Minimum
Dec 2019
1.407B
Maximum
Jun 2023
653.70M
Average
597.77M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 70.16B |
| Alnylam Pharmaceuticals Inc | 32.35M |
| BioCryst Pharmaceuticals Inc | -468.56M |
| Biomarin Pharmaceutical Inc | 5.413B |
| National Healthcare Corp | 983.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.798B |
| Total Liabilities (Quarterly) | 639.18M |
| Debt to Equity Ratio | 0.2516 |
| Current Ratio | 4.841 |
| Net Debt Paydown Yield | -0.06% |